Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b-2, study. - Finn RS; Ryoo BY; Hsu CH; Li D; Burgoyne AM; Cotter C; Badhrinarayanan S; Wang Y; Yin A; Edubilli TR; Mahrus S; Secrest MH; et al. (The Lancet. Oncology, 2025)